Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Active-comparator-controlled, Multicenter Study to Assess the Safety and Efficacy of Different Doses of BAY1213790 for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Primary Total Knee Arthroplasty, Open-label to Treatment and Observer-blinded to BAY1213790 Doses

NCT03276143 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03276143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03276143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Active-comparator-controlled, Multicenter Study to Assess the Safety and Efficacy of Different Doses of BAY1213790 for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Primary Total Knee Arthroplasty, Open-label to Treatment and Observer-blinded to BAY1213790 Doses
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
September 21, 2017
Completion date
January 2, 2019
Enrollment
813 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

knee arthroplasty, total